This presentation summarize India's potential to become virtuoso in Pharmaceutical domain.

1. Why to choose India?
1
HARSHDIP ACHARYA

2. Introduction
 Serious pressure being felt by Pharmaceutical companies owing to sluggish
growth rate in Key markets.
 North America, Japan and Europe jointly accounts for 82% of audited and
unaudited drug sales.
 Higher R&D cost, pressure from payers and providers for low cost medicine.
2

3. India
 Rapidly growing population- creating a large middle class which can afford the
western medicine.
 Changing epidemiological profile; rise in chronic disease segment
 Manufacturing expertise in Generics and Vaccines
 Worlds second biggest pool of English Speakers
3

4. Shifts in Indian Economy
 Switching from Agrarian to Service economy aided by demographic profile and
robust service sector
 Expanding Pharmaceutical market
 Till 2028, it is supposed to be one of largest pool of diabetic patients
 Increasing expenditure on Health by Private and Government agencies
 Improving in Manufacturing standards owing to scrutiny by Regulators
4

5. Opportunities
 Significant volume in OTC markets; Potential segment to enter into
 Reaching the untapped Rural market, which accounts for 70% population
shelter.
 Increasing R&D initiatives
 Overall cost are only 50% of USA
 Biotech and Biosimilars
 Bionformatics is in growing phase.
 Growing Medical Device Market
5

6. Evolving Business Models
6

7. Practical concerns
 Infrastructure
 Tax Environment
 Counterfeiting
 Patent related issues “Patent Hostile country”
7

8. 8